How Long Does Testicular Cancer Take to Spread?
Progression
Testicular cancer (specifically, germ cell tumors) is an aggressive cancer, doubling in size every 10 to 30 days. If not treated, testicular cancer can spread via the lymphatic pathways. The lymph glands around the aorta and the vena cava at the level of the kidneys are the first to be involved. Testicular cancer then may spread to other lymph glands. In advanced cases it can spread to the lungs, liver, brain, bone, kidney, adrenal gland, and spleen. Without treatment, a testicular cancer patient will die on average 2-3 years from time of diagnosis.
If you are experiencing serious medical symptoms, seek emergency treatment immediately.
- Testicular cancer (specifically, germ cell tumors) is an aggressive cancer, doubling in size every 10 to 30 days.
- If not treated, testicular cancer can spread via the lymphatic pathways.
Staging
How Fast Does Ovarian Cancer Spread?
Learn More
Testicular cancer is staged using various systems in different countries. Using the TNM Classification of Malignant Tumors, testicular cancer is staged as follows: Stage I--tumor confined to testes; Stage II--tumor has spread to para-aortic lymph glands; Stage III--lymph gland involvement in chest or neck; Stage IV--cancer has spread outside of lymph glands, such as to lungs or liver.
Treatment
Because of modern advancements in medicine, testicular cancer has one of the highest cure rates of all cancers. In 1970, a man with testicular cancer had only a 10% chance of survival. Today, modern treatments are so successful that with early detection the cure rate is almost 100%. Even if the cancer has widely metastasized, the cure rate is still 80%. Treatments include orchiectomy (removal of testes), removal of lymph glands around the aorta and vena cava, radiation therapy and chemotherapy. Most of the treatment options will affect fertility.
- Because of modern advancements in medicine, testicular cancer has one of the highest cure rates of all cancers.
- Today, modern treatments are so successful that with early detection the cure rate is almost 100%.
See Your Doctor
Signs of End Stage Breast Cancer
Learn More
According to the American Cancer Society, about 8,400 cases of testicular cancer will be diagnosed in the United States each year, and 380 will die from the disease. The lifetime incidence of testicular cancer is 1 in 300. Some experts recommend regular monthly testicular self-examination. Any irregularity of your testes should be reported to your doctor immediately. Testicular cancer usually presents as a hard, painless lump in the scrotum; unexplained enlargement of a testicle; or an unexplained pain, ache or swelling within the scrotum. High-risk patients should be extra vigilant. High risk is defined as having an undescended testes, a previous history of a testes tumor, a brother or father with a testes tumor, and infertile men. Early treatment is essential.
- According to the American Cancer Society, about 8,400 cases of testicular cancer will be diagnosed in the United States each year, and 380 will die from the disease.
- High risk is defined as having an undescended testes, a previous history of a testes tumor, a brother or father with a testes tumor, and infertile men.
Related Articles
References
- Facts About Testicular Cancer: Testicular Cancer Statistics. American Cancer Society. May 17, 2018.
- Light DE, Leslie SW. Testicular Seminoma. StatPearls Publishing LLC.; 2019.
- Testicular Cancer Risk Factors: Risks For Testicular Cancer. American Cancer Society. May 17, 2018.
- Shanmugalingam T, Soultati A, Chowdhury S, Rudman S, Van hemelrijck M. Global incidence and outcome of testicular cancer. Clin Epidemiol. 2013;5:417-27. doi:10.2147/CLEP.S34430
- Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O. Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med. 2007;356(18):1835-41. doi:10.1056/NEJMoa067588
- Tan IB, Ang KK, Ching BC, Mohan C, Toh CK, Tan MH. Testicular microlithiasis predicts concurrent testicular germ cell tumors and intratubular germ cell neoplasia of unclassified type in adults: a meta-analysis and systematic review. Cancer. 2010;116(19):4520-32. doi:10.1002/cncr.25231
- Goedert JJ, Purdue MP, Mcneel TS, Mcglynn KA, Engels EA. Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1266-9. doi:10.1158/1055-9965.EPI-07-0042
- Srivastava A, Kreiger N. Cigarette smoking and testicular cancer. Cancer Epidemiol Biomarkers Prev. 2004;13(1):49-54. doi:10.1158/1055-9965.EPI-03-0133
- Gurney J, Shaw C, Stanley J, Signal V, Sarfati D. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015;15:897. doi:10.1186/s12885-015-1905-6
- Markt SC, Miller R, Odonnell E, et al. BMI at diagnosis and adverse outcomes among men with malignant testicular germ cell tumors. Journal of Clinical Oncology. 2015;33(7_suppl):400-400. doi:10.1200/jco.2015.33.7_suppl.400
- Huang S, Signal V, Sarfati D, et al. Physical activity and risk of testicular cancer: a systematic review. BMC Cancer. 2018;18(1):189. doi:10.1186/s12885-018-4093-3
- Riggin AJ, Siddiqui MM. Development of intermediate and high-risk prostate cancer after testicular cancer. Journal of Clinical Oncology. 2015;33(7_suppl):177-177. doi:10.1200/jco.2015.33.7_suppl.177
- Accardo, G.; Vallone, G.; Esposito, D. et al. Testicular parenchymal abnormalities in Klinefelter syndrome: a question of cancer? Examination of 40 consecutive patients. Asian J Androl. 2015; 17(1):154-8. DOI: 10.4103/1008-682X.128514.
- Akers, O.; Ekbom, A.; Sparen, P. et al. Body Size and Testicular Cancer. J Nat Cancer Institute. 2000; 92(13): 1093-96. DOI: 10.1093/jnci/92.13.1093.
- Gurney, J.; Shaw, C.; Stanley, J. et al. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015; 15:897. DOI: 10.1186/s12885-015-1905-6.
- Kier, M.; Lauritson, J.; Almstrup, K. et al. Screening for carcinoma in situ in the contralateral testicle in patients with testicular cancer: a population-based study. Annal Oncology. 2015; 26(4):737-42. DOI: 10.1093/annonc/mdu585.
- Lerro, A.; McGlynn, K.; and Cook, M. A systematic review and meta-analysis of the relationship between body size and testicular cancer. Brit J Cancer. 2010; 103:1467-74. DOI: 10.1039/sj.bjc.6605934.
- Litchfield, K.; Thomson, H.; Mitchell, J. et al. Quantifying the heritability of testicular germ cell tumour using both population-based and genomic approaches. Scientific Reports. 2015; 5:13889. DOI: 10.1038/srep13889.
- Markt, S.; Miller, R.; O'Donnell, E. BMI at diagnosis and adverse outcomes among men with malignant testicular germ cell tumors. J Clin Oncology. 2015; 33(Suppl 7):400. DOI: 10.1200/jco.2015.33.7-suppl.400.
- Riggins, A. and Siddiqui, M. Development of intermediate and high-risk prostate cancer after testicular cancer. J Clin Oncology. 2015; 33(Suppl 7):177. DOI: 10.1200/jco.2015:33.7_suppl.177.
Writer Bio
Drue Tibbits is a writer based in Central Florida, where she attended Florida Southern College. Her articles have appeared in Entrepreneur and Your Home magazines. She has also been profiled in the Florida Today newspaper and the Writer's Digest magazine. In addition to writing brochure copy for local businesses, she helps new start-up companies develop a local image presence.